Announcement on Result of Shareholding Reduction by Shareholder
Filed with SSE · · 3 pages · Chinese
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. on 6ix
Earlier from Shanghai Fudan Zhangjiang Bio Pharmaceutical
- Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025
- Announcement on Resolutions of the 10th Meeting of the 8th Board of Supervisors
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Indicative Announcement on Change of Equity to 5% for Shareholders with Over 5% Shares
- Announcement on Implementation of Dividend Distribution for 2024
Later from Shanghai Fudan Zhangjiang Bio Pharmaceutical
- Announcement on the Voluntary Disclosure of Non-Approval of the Marketing Authorization Application for Obeticholic Acid Tablets for the Treatment of Primary Biliary Cholangitis
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Amending the Articles of Association and Its Annexes and Canceling the Board of Supervisors
- Announcement on Changing Some Investment Projects Financed by Raised Funds
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical